Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.
There are no recent dividends present for RLAY.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.